BioPharmSignal logoBioPharmSignal

Biotech News

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

ANI Pharmaceuticals (ANIP)ANI PharmaceuticalsEarnings

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its third quarter 2026 financial results on Thursday, November 5, 2026, at 8:00 a.m. ET.

Related news

ANIPANI Pharmaceuticals2026-07-24 10:50 EST

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

ANIPANI Pharmaceuticals2026-04-24 10:50 EST

ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

CHRSCoherus BioSciences, Inc.2026-10-26 13:30 EST

Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026

AMRXAmneal Pharmaceuticals2026-11-03 11:00 EST

Amneal Reports Third Quarter 2026 Financial Results

AMRXAmneal Pharmaceuticals2026-10-08 12:00 EST

Amneal to Report Third Quarter 2026 Results on November 3, 2026

CHRSCoherus BioSciences, Inc.2026-07-22 17:36 EST

Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026

ALVOAlvotech2026-10-28 11:00 EST

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

ALVOAlvotech2026-08-19 20:30 EST

Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

View all latest news

ANI Pharmaceuticals

Rare-Disease and Specialty Pharmaceuticals ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets. Its model combines branded specialty products with a portfolio of generic medicines. Cortrophin Gel Purified Cortrophin Gel is an adrenocorticotropic hormone...

Recent company news

ANIPANI Pharmaceuticals2026-11-05 11:51 EST

ANI Pharmaceuticals Reports Third Quarter 2026 Financial Results

ANIPANI Pharmaceuticals2026-11-05 11:50 EST

REPEAT – ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business

ANIPANI Pharmaceuticals2026-11-05 06:33 EST

ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business

ANIPANI Pharmaceuticals2026-11-03 11:55 EST

ANI Pharmaceuticals to Present at Upcoming November Investor Conferences

ANIPANI Pharmaceuticals2026-10-23 10:55 EST

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

Stock data

Close
69.62 USD
Market cap
1.7B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States